Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0028754
Disease: Obesity
Obesity
0.580 Biomarker disease BEFREE Cytochrome P450 2E1 (CYP2E1) can be induced by diabetes mellitus, nonalcoholic liver disease, and obesity. 30991910 2019
CUI: C0028754
Disease: Obesity
Obesity
0.580 AlteredExpression disease BEFREE CYP2E1 activity and children with obesity: possible confounding factors. 30334271 2019
CUI: C0028754
Disease: Obesity
Obesity
0.580 Biomarker disease BEFREE Our study is consistent with previous research and further claimes that CNVs containing CYP2E1 may be related to HTG and obesity. 29129660 2018
CUI: C0028754
Disease: Obesity
Obesity
0.580 AlteredExpression disease BEFREE The enhanced levels of CYP2E1 and increased oxidative stress in obesity play a significant role in this process. 25180626 2014
CUI: C0028754
Disease: Obesity
Obesity
0.580 Biomarker disease CTD_human Obese mouse ovaries had decreased Irs1, Foxo3a, Cyp2e1, MiR-103, and MiR-21 but increased Kitlg, Akt1, and miR-184 levels relative to lean littermates. 23954404 2013
CUI: C0028754
Disease: Obesity
Obesity
0.580 Biomarker disease BEFREE The protein encoded by CYP2E1 involves the synthesis of cholesterol, steroids and other lipids, which may have a potential impact on obesity. 23175694 2013
CUI: C0028754
Disease: Obesity
Obesity
0.580 Biomarker disease BEFREE We investigated a possible association between alcoholism, cigarette smoking, obesity and CYP2E1 RsaI and 96-bp insertion genetic polymorphisms with risk for colorectal cancer (CRC). 23007992 2012
CUI: C0028754
Disease: Obesity
Obesity
0.580 Biomarker disease RGD These results suggest that CYP2E1 may be induced in liver and fat of obese patients, thereby potentially altering the disposition kinetics of not only CZX, but also other lipophilic drugs metabolized by CYP2E1. 17049493 2007
CUI: C0028754
Disease: Obesity
Obesity
0.580 Biomarker disease BEFREE These trends are consistent with the characteristic phenotype of obesity in the transgenic rat because CYP4A1 and CYP2E1 enhance fatty acid excretion and glyconeogenesis from fatty acids respectively. 10647907 1999
CUI: C0028754
Disease: Obesity
Obesity
0.580 Biomarker disease BEFREE A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. 9772223 1998